OncoTest Teva - 16.7.2018

Steven Shak, MDReal World Evidence of OncotypeDX Use and Outcomes in the US SEER Registry to Complement the Results Observed in randomized Trials

Steven Shak, MD
Chief Scientific Officer at Genomic Health Executive Vice President of Research and Development Genomic Health I Inc.Redwood City, California

 


חזרה לדף הסיקור
e-Med ערוץ החדשות הרפואיות של ישראל